We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

190 hedge funds and large institutions have $1.92B invested in ChemoCentryx, Inc. in 2021 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 25

153% more capital invested

Capital invested by funds: $761M → $1.92B (+$1.16B)

120% more call options, than puts

Call options by funds: $70M | Put options by funds: $31.8M

36% more funds holding

Funds holding: 140 → 190 (+50)

12% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 52

Holders
190
Holders Change
+50
Holders Change %
+35.71%
% of All Funds
2.92%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
76
Increased
46
Reduced
52
Closed
25
Calls
$70M
Puts
$31.8M
Net Calls
+$38.2M
Net Calls Change
+$10.2M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$56.4M
2
BBA
Baker Bros. Advisors
New York
+$46.7M
3
Millennium Management
Millennium Management
New York
+$33.2M
4
PA
Perceptive Advisors
New York
+$30.4M
5
Marshall Wace
Marshall Wace
United Kingdom
+$29.1M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$67M
2
WA
Wasatch Advisors
Utah
-$27.3M
3
Citadel Advisors
Citadel Advisors
Florida
-$14.7M
4
Wells Fargo
Wells Fargo
California
-$9.95M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$9.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
101
Caption Management
Oklahoma
$990K -$6.51M -185,482 -87%
HT
102
HAP Trading
New York
$883K -$420K -11,964 -33%
TCM
103
TimesSquare Capital Management
New York
$874K +$842K +24,000 New
PAM
104
Panagora Asset Management
Massachusetts
$813K +$149K +4,256 +24%
ProShare Advisors
105
ProShare Advisors
Maryland
$788K -$6.81K -194 -0.9%
VOYA Investment Management
106
VOYA Investment Management
Georgia
$762K +$9.58K +273 +1%
ECM
107
EMC Capital Management
Texas
$762K +$734K +20,922 New
BC
108
Birchview Capital
Vermont
$728K -$176K -5,000 -20%
QT
109
Quantamental Technologies
New York
$727K +$701K +19,962 New
MIM
110
MetLife Investment Management
New Jersey
$699K – – –
Osaic Holdings
111
Osaic Holdings
Arizona
$680K +$464K +13,216 +242%
PCM
112
Prelude Capital Management
New York
$674K +$649K +18,500 New
State Board of Administration of Florida Retirement System
113
State Board of Administration of Florida Retirement System
Florida
$649K -$35 -1 -0%
MAM
114
Martingale Asset Management
Massachusetts
$643K -$601K -17,122 -49%
EAM
115
Erste Asset Management
Austria
$598K – – –
MLICM
116
Metropolitan Life Insurance Company (MetLife)
New York
$546K – – –
TRCT
117
Tower Research Capital (TRC)
New York
$521K +$67.6K +1,926 +16%
ACM
118
AlphaCrest Capital Management
New York
$513K +$495K +14,100 New
GTCM
119
Gyon Technologies Capital Management
New Jersey
$494K +$477K +13,579 New
SO
120
STRS Ohio
Ohio
$491K +$35.1K +1,000 +8%
AIM
121
Aigen Investment Management
New York
$484K +$492K +14,010 New
ASRS
122
Arizona State Retirement System
Arizona
$480K -$4.53K -129 -1%
EGM
123
Engineers Gate Manager
New York
$446K +$430K +12,240 New
Handelsbanken Fonder
124
Handelsbanken Fonder
Sweden
$441K – – –
LFAS
125
Level Four Advisory Services
Texas
$427K +$412K +11,740 New
3 4
5
6 7

CCXI Hedge Fund Activity: Q4 2021 in Review

190 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2021, worth a combined $1.92B — up 153% from $761M a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new CCXI positions and 25 closed out — a net gain of 51 holders — while 46 added to existing stakes and 52 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $56.4M. The largest seller was State Street, cutting an estimated $67M.

  • 190 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2021, up from 140 in Q3 2021.
  • Funds reported $1.92B of ChemoCentryx, Inc. stock for Q4 2021, up 153% quarter-over-quarter.
  • 76 funds opened new ChemoCentryx, Inc. positions in Q4 2021 and 25 closed out, a net change of +51 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2021 was Pictet Asset Management (Switzerland), an estimated $56.4M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2021 was State Street, an estimated $67M sold.

Based on aggregated 13F filings for Q4 2021.